Eugene A. Bauer's most recent trade in Evommune Inc. was a trade of 51,117 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Evommune Inc | Eugene A. Bauer | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 51,117 | 51,117 | - | - | Employee Stock Option (Right to Buy) | |
| Evommune Inc | Eugene A. Bauer | Director, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.84 per share. | 09 Dec 2025 | 1,478 | 270,818 | - | 17.8 | 26,368 | Common Stock |
| Evommune Inc | Eugene A. Bauer | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Evommune Inc | Eugene A. Bauer | Director, Chief Medical Officer | 07 Nov 2025 | 206,355 | 0 | - | - | Series Seed Preferred Stock | ||
| Evommune Inc | Eugene A. Bauer | Director, Chief Medical Officer | 07 Nov 2025 | 25,812 | 272,296 | - | - | Common Stock | ||
| Evommune Inc | Eugene A. Bauer | Director, Chief Medical Officer | 07 Nov 2025 | 12,500 | 0 | - | - | Series B Preferred Stock |